ABSTRACT
To investigate whether the expression of exogenous heme oxygenase-1 (HO-1) gene within vascular smooth muscle cells (VSMC) could protect the cells from free radical attack and inhibit cell proliferation, we established an in vitro transfection of human HO-1 gene into rat VSMC mediated by a retroviral vector. The results showed that the profound expression of HO-1 protein as well as HO activity was 1.8- and 2.0-fold increased respectively in the transfected cells compared to the non-transfected ones. The treatment of VSMC with different concentrations of H2O2 led to the remarkable cell damage as indicated by survival rate and LDH leakage. However, the resistance of the HO-1 transfected VSMC against H2O2 was significantly raised. This protective effect was dramatically diminished when the transfected VSMC were pretreated with ZnPP-IX, a specific inhibitor of HO, for 24 h. In addition, we found that the growth potential of the transfected cells was significantly inhibited directly by increased activity of HO-1, and this effect might be related to decreased phosphorylation of MAPK. These results suggest that the overexpression of introduced hHO-1 is potentially able to reduce the risk factors of atherosclerosis, partially due to its cellular protection against oxidative injury and to its inhibitory effect on cellular proliferation.
Similar content being viewed by others
INTRODUCTION
IHeme oxygenase (HO) is a microsomal enzyme that catalyzes the degradation of heme into biliverdin, which is subsequently reduced to bilirubin, one atom of iron and one molecule of carbon monoxide (CO). There has been a recent explosion of interest in heme oxygenase-1 (HO-1) as its breakdown products play many other vital physiological and pathological roles in diverse biological processes1. Enhanced activity of HO-1 has been potentially associated with cellular protection. Conversely, it was found that patient with HO-1 deficiency was more susceptible to endothelial cell injury2. Similarly, HO-1 gene knockout mice revealed more sensitive to a wide variety of oxidative stimuli, such as heme and hydrogen peroxide3, suggesting that increased HO-1 activity may be beneficial in resistance to oxidants.
Nowadays, more abundant vascular damages are evidenced by the oxygenation of endothelial cells and smooth muscle cells, and the oxygen free radical (OFR) attack seems to contribute dominant pathogenesis of vascular disease in great extent. The elevated plasma levels of low density lipoproteins (LDL) and their oxidative modifications are recognized as main risk factors of atherosclerosis and vascular dysfunction4. In addition, oxidative agents and oxidized LDL modulate the function of vascular cells, especially the vascular smooth muscle cells (VSMC), which migrate expansively into intima and proliferate noticeably, resulting in the pathology of occluding arterial lesions during atherogenesis5. In parallel, more attention has been increasingly paid to antioxidant effect of HO-1 for cardioprotection, because much more cellular protective evidences of HO-1 induction were produced against oxidative damage6. It has been recently shown that there is a diminished glutathione-related enzymatic antioxidant shield within human atherosclerosis lesions7 correlative with the increased expression of HO-18. These phenomenons imply that the induction of HO-1 might function as an alternative antioxidant defense mechanism. In this study, a retroviral vector containing the human HO-1 gene was constructed and transfected into rat VSMC to investigate the cellular protection of HO-1 against oxidant-induced injury and the effects of overexpression of HO-1 on cell proliferation.
MATERIALS AND METHODS
Chemical reagents
Collagenase I (Sigma); DMEM and fetal calf serum (GIBCO BRL); TRIzol (GIBCO BRL); Lipofectin (BM); random primer labeling kit (Promega); anti-mouse SMC-a-actin monoclonal antibody (Sigma); anti-rat HO-1 polyclonal antibody (Affiniti, UK); anti-rabbit-MAPK (p44/42) polyclonal antibody (Sigma); anti-rabbit-phospho-MAPK (Thr202/Tyr204)polyclonal antibody (Promega); ECL (Santa Cruz); Zinc-protoporphyrin IX (Sigma); MTS (Promega).
Cell culture
The blood vessel was isolated from thoracic aorta of male Sprague-Dawley rats weighing 200-250g. One mm3 of tissue slice was made and digested with collagenase I at 37 °C overnight. VSMC obtained were cultivated in Dulbecco's Modified Eagles Medium (DMEM) containing 10% fetal calf serum (FCS) in a 5% CO2 humidified-atmosphere incubator. The VSMC grown in DMEM medium appeared as a typical morphology of “hill and valley” The immunohistochemistry staining with a monoclonal antibody against α-actin was performed to identify the eventually co-cultured fibroblast cells. The retroviral packaging cell line, PA317, was used for the generation of helper-free recombinant retrovirus. The cells were cultured in DMEM supplemented with 10% FCS, 100U/ml penicillin and 100 μg/ml streptomycin. PA317 cells were incubated at 37°C in a 5% CO2 humidified-atmosphere. For experiments, the cells were then sub-cultured into 100mm-culture dishes or in 24-well plates. The VSMC between passages 2 and 25 were utilized in all experiments.
Construction of the retroviral vector XM6/hHO-1
XM6 is a replication-defective retroviral vector that is controlled by 5'LTR promoter for transcription9. A 987bp HindIII-cleaved fragment of hHO-1 cDNA was released from plasmid pGEM7zf/hHO-1 (kindly provided by Prof. Abraham NG, New York), and inserted into HindIII site of XM6 vector. The orientation of recombinant construct was determined by restriction digestion with ApaI and the correct plamsid construct, designated as XM6/hHO-1, was solely chosen for the subsequent viral infection.
Packaging of retroviral recombinant and transfection of cells 10
XM6 and XM6/hHO-1 DNA were transfected into PA317 cells with Lipofectin according to the manufacturer's manuals. After selected with 400 μg/ml G418 for 2 w, the individual cell-cluster of G418-resistant was formed. The well-isolated clusters were trypsinized and harvested for continuous enrichment to the confluency of 70 ∼ 80%. For each isolated clone, the viral titer was determined and only cell clone with titers beyond 1×106 colony-forming units (CFU) per ml was exclusively adopted in the following experiments. The medium containing the recombinant XM6/hHO-1virus was preserved at −70°C till use.
A totally of 2.5×105 VSMC were seeded in 100 mm-dishes and allowed to grow until 50 ∼ 70% of confluence were achieved. The medium was replaced with 5ml of virus-containing supernatant supplemented by 8 μg/ml polybrene. After incubation for 6 h, the virus supernatant was replaced with fresh complete medium and was incubated for a further 24 h. After selection with 400 μg/ml of G418 for 2 w, individual G418-resistant clones were obtained. The VSMC transfected with XM6 or XM6/hHO-1 were nominated VSMC/XM6 and VSMC/HO-1, respectively.
Southern and Northern blot analysis 11
Genomic DNA from VSMC, VSMC/XM6 and VSMC/HO-1 cells was isolated. 15 μg of each cell DNA was digested with 20 U of BamH I and electrophorized using 1.0% agarose gel. DNA in the gel was capillary blotted onto nylon membrane (Bio-Rad). Total cellular RNA of the above-mentioned cells and PA317, PA317/XM6 and PA317/HO-1 as well were extracted using the TRIzol reagent according to the instructions from the manufacturer. A total of 30 μg RNA was denatured, electrophorized on 1.0% agarose gel contained 2.2 M-formaldehyde/1 × MOPS and transferred onto a nylon membrane. The membranes were hybridized with either hHO-1 cDNA or 450bp fragment of Neomycin cDNA. To verify the uniformity of RNA loading, a rat S26 cDNA probe was rehybridized as internal control. All the cDNA probes for the hybridization were labeled with α-32P-[dCTP] using random primer labeling kit. The Southern and Northern blot signals on the membrane were visualized by autoradiography on the Kodak X-Omat films (Eastman Kodak Co.) at −70°C.
Cell lysis and Western blot
In parallel to the Northern blot, cellular protein was prepared and Western blot for detection of HO-1 protein expression was performed as described12. Briefly, the cells were harvested, washed with phosphate buffer solution (PBS, pH 7.4) and lysed with ice-cold lysis buffer (50 mM Tris-HCl, pH 7.2; 150 mM NaCl; 1 mM EDTA; 1% Triton X-100; 0.1% aprotinin; 0.1% SDS; 1 mM PMSF). The lysate was clarified by centrifugation (14,000 g, 4°C, 30 min). 80 μg of the protein from supernatant was fractionated by 12% SDS-PAGE and electrotransferred onto a nitrocellulose membrane. The blots were blocked in 5% non-fat milk at 4°C overnight. In the next day, the membranes were briefly washed twice with Tris-buffered saline containing 0.1% Tween 20 (TBST) and incubated with rabbit anti-HO-1 polyclonal antibody (1:500 dilution with 0.5% non-fat milk TBST) for 2 h. Then, the membranes were washed three times each for 10 min with TBST and incubated with peroxidase-confugated goat anti-rabbit IgG (1:2000 dilution) for 1 h. Afterward, the membranes were developed with enhanced chemiluminescence (ECL) reagents and the positive signals were exposed to X-ray films. The densities of the immunoblots were scanned with laser densitometer (Bio-Rad).
For detecting the expression and phosphorylation of mitogen-activated protein kinase (MAPK), Western blot was done by the same procedures as above-described, but different concentration of first antibody (1:2000 dilution for anti-MAPK antibody and 1:1000 dilution for anti-phospho-MAPK antibody) and total 30 μg of the protein from cell supernatant was loaded. In addition, 40 mM NaF was supplemented during preparation of cell lysate to prevent dephosphorylation induced by protein phosphatase.
Measurement of HO-1 activity 13
Heme oxygenase activity was measured with the microsomal fractions of culture cells by determining the level of bilirubin formation. The cells were harvested, washed twice with PBS (pH 7.4). The cell suspension was centrifuged at 1,000 g for 15 min at 4°C.The pellets was homogenized and centrifuged at 18,000 g for 10 min. The supernatant was collected and recentrifuged at 100,000 g for 60 min. Microsomal fractions were resuspended in 0.1 M potassium phosphate buffer (pH 7.4). The rat hepatic biliverdin reductase was prepared by (NH3)2SO4 precipitation. Microsomes (0.5 mg) were incubated with Hemin (20 μM), NADP (0.8 mM), Biliverdin reductase (4 mg), glucose-6- phosphate (4 mM), and glucose-6-phosphate dehydrogenase (1 U) in 1 ml for 15 min at 37°C in darkness, and the reaction was stopped by placing the tubes in ice. The optical absorption of bilirubin at 463 nm was measured against a basal absorption at 530 nm (extinction coefficient, 40 mM−1cm−1 for bilirubin). Heme oxygenase activity is expressed as nanomole of bilirubin per milligram of protein per hour (nM bilirubin mg protein−1 h−1). The protein of microsomes was determined by the method of Lowry with BSA as a standard.
Measurement of cGMP concentration
Cellular cGMP content was determined using 125I-labeled radioimmunoaasay kit (Yahui, China). Briefly, the cells were harvested in ice-cold PBS (pH 7.4), sonicated and centrifuged at 8000g for 10 min at 4°C. Supernatants were stored at −80°C until analysed. cGMP concentration was normalized to protein content by the methods of Lowry.
Cell viability and LDH leakage
Cell viability was detected by the trypan blue exclusion assay. VSMC were seeded in 24-well plates (8×104 cells/well) and were cultured with fresh complete medium for 24 h followed by incubation with PBS (pH 7.4) containing different concentrations of H2O2 (200, 400, 600 μM) for 6 h. The culture medium was collected to measure lactate dehydrogenase (LDH) activity according to the method described by Wroblewski F14. Subsequently, the cells were trypsinized with 0.1 ml of 0.1% trypsin-EDTA followed by neutralization with 0.4 ml of serum-contained culture medium. After stained with trypan blue, the numbers of cells excluding or stained with trypan blue were counted by using a hemocytometer under light microscope. Cell viability was calculated as the percentage of viable (unstained) cells of the total (stained and unstained) cells.
Cell growth and flow cytometry assay
Cell growth was measured by non-radioactive proliferation assay based upon the cellular conversion of the tetrazolium salt, MTS [3-(3,5-dimethylthialzol-2-yl)-5-(3 carboxymethoxypheny)-2-(4-sulphophenyl)-2H-tetrazolium], into a formazan product that is soluble in culture medium15. Briefly, VSMC, VSMC/XM6 and VSMC/HO-1 cells were cultured in serum-starved medium for synchronization of cell cycle. 24 h later, the above three cells were trypsinized and inoculated into 96-well plates (5×103cells/well). MTS reagent was added into the medium 2 h prior to measurement and the absorption was determined with Microplate Reader (Bio-Rad) at 490 nm.
Flow cytometric determination of DNA content was used as another index of cell proliferation (16). The synchronized cells were trypsinized, harvested and inoculated into 6-well plates (5×105cells/well). 24 h later, cells were collected, washed with PBS and centrifuged by at 2000 rpm for 10 min. The pellets of cells were resuspended in 80% ethanol and stored at 4°C for 24 h. The cells were washed twice with PBS and the pellet was resuspended in PBS containing 100 μg/ml RNase A, incubated at 37°C for 30 min, stained with 50 μg/ml phosphatidylinositol (PI), and analyzed by flow cytometry for DNA analysis.
Statistical analysis
All values were expressed as means±SD. Statistical significance was determined by one-way ANOVA. P values < 0.05 were considered significant.
RESULTS
Efficiency of gene transfer and overexpression of hHO-1 gene
The G418-resistant PA317 cells transfected either with XM6 or XM6/hHO-1 were evaluated for the potential of the production of recombinant retrovirus in culture medium. The results showed that the titers of 1.3×106 CFU/ml in PA317/XM6 and 1.2×106 CFU/ml in PA317/HO-1 were obtained, respectively. The Northern blot analysis in Fig 1A indicated that human HO-1 mRNA was solely expressed in PA317/HO-1, but not in PA317/XM6 and PA317 wild-type cells. After infected by PA317/XM6 and PA317/HO-1 virus and screened with the G418, VSMC clusters were obtained. Total RNA from 5 individual cell clones, of which three were PA317/HO-1-infected and two were PA317/XM6, was prepared and expression of hHO-1 gene was analyzed. As indicated in Fig 1B, all the retrovirus-infected VSMC could equally express S26 and neor, however, neither wild-type VSMC nor XM6-transfected cells produced a positive band of hHO-1. hHO-1 mRNA was detected only in HO-1-transfected cells. Meanwhile, an equalization of S26 signals revealed the unity amounts of RNA loaded on to the filters in each lane of the paired experiments. Genomic DNA hybridization with hHO-1 cDNA probe as viewed in Southern blot strongly demonstrated the integration of recombinant DNA into the host VSMC (data not shown).
Enhancement of HO activity and HO-1 protein expression in VSMC/HO-1 cells
The basal levels of HO activity between wild-type VSMC and XM6-transfected VSMC were found no significance (P > 0.05). Whiles, HO activity in the hHO-1-transfected VSMC was remarkably increased by 2.0-fold compared with that in control VSMC, P < 0.05 (Fig 2A). Meanwhile, HO-1 protein expression gave rise to a strong signal for the HO-1-transfected VSMC. The enhancement of HO activity was apparently identical to the hHO-1 mRNA expression. The quantitative evaluation of Western blot signals as scanned by densitometry indicated that HO-1 protein in hHO-1-transfected VSMC was increased 1.8-fold compared with nontransfected cells (Fig 2B). These data clearly demonstrated that the enhancement of HO activity was coordinated with the protein overexpression ofHO-1. Moreover, the introduction of exogenous HO-1 gene mediated by retrovirus allowed the functional expression of this foreign gene in the target VSMC.
Anti-oxidant effects of hHO-1 gene transfer
The exposure of VSMC to a series of concentration of H2O2 (200 ∼ 600 μ M) led to severe leakage of intracellular LDH. The results showed that VSMC, VSMC/XM6 and VSMC/HO-1 cells without exposure to H2O2 were more than 97% viable. Whereas, the treatment of these cells with H2O2 for 6 h resulted in apparent increment in cell death and LDH leak-out as dose-dependent pattern. However, the cell damages in hHO-1-transfected VSMC, under similar dose of H2O2, were significantly relieved as compared with nontransfected or XM6-transfected VSMC. As shown in Fig 3A and Fig 3C, the more survivals of hHO-1 transfected VSMC were observed and LDH leakage was markedly declined under a sub-lethal or lethal dose of H2O2. In contrast, the protective effect was re-masked, if the cells were pretreated with a defined inhibitor of HO, zinc-protoporphyrin (20 μM) for 24 h (Fig 3B, Fig 3D). These results indicated that overexpression of gene-transferred hHO-1 in rat VSMC was able to enhance the cell resistant to oxidant-induced injury elicited by exposure to H2O2.
Inhibition of cell proliferation
As shown in Fig 4A, hHO-1-transfected VSMC appeared a slower growth rate than that of wild-type VSMC and XM6-transfected VSMC. The antiproliferative effect of overexpression of hHO-1 was also evidenced by flow cytometry assay. Although VSMC in the normal arterial media in vivo are quiescent and contractile, the isolation and culture of VSMC in vitro are associated with a similar phenotypic change from a contractile to a synthetic, proliferative phenotype. As shown in Fig 5A, 15% of the wide-type VSMC entered the S-phase of the cell cycle, whereas, only 5% of hHO-1 transfected VSMC occurred in S-phase, and 91% of hHO-1-transfected cells were in the growth-arrested phase (G0/G1) of the cell cycle. In addition, transfection of vector XM6 in VSMC had no effect on cell DNA synthesis. In contrast, The anti-proliferation effect of HO-1 was reversed by pretreating the cells with 20 μM ZnPP-IX for 24 h (Fig 4B, Fig 5B). These results indicated that overexpression of gene-transferred hHO-1 in rat VSMC was able to inhibit cell proliferation.
Increase of cellular cGMP and decrease of MAPK phosphorylation
Although there was no significant difference in the basal level of endogenous cellular cGMP between non-transfected and XM6-transfected VSMC (1.07±0.38 and 1.19±0.33 pmol/mg respectively), the cGMP content in hHO-1-transfected VSMC was markedly increased (2.68±0.59 pmol/mg) compared with that in wild-type VSMC (P < 0.01). Moreover, the elevation of cGMP level could be diminished by pretreatment of all cells with ZnPP-IX for 24 h (0.84±0.24, 0.91±0.17 and 1.11±0.2 pmol/mg, respectively), indicating that the augmentation of cGMP level was mediated by the overexpression of HO-1.
It is well known that MAPK is a converging point for various signal pathways leading to cell proliferation. To investigate the possible mechanism of the anti-proliferative effect of HO-1, the p44/42-MAPK expression and MAPK phosphorylation level were measured using Western blot. As shown in Fig 6, the expression of p44/42-MAPK was no significant difference in three types of the cells, but the MAPK phosphorylation level in hHO-1-transfected VSMC was 43% decreased compared with that in wild-type VSMC (P < 0.01).
DISCUSSION
Transfection of mammal cells with retroviral vector possesses considerable advantages including relatively high infective efficiency and stable expression. Although adenovirus has been used in other experiment for investigate the roles of HO-1 in the development of atherosclerosis17, the major shortcomings of this viral vector are often reported as to high immunogenicity which may lead to inflammatory reactions or even death in the host18. Thus, retroviral vector is more suitable for delivering a foreign gene into mammalian cells19. In this study, the retrovirus containing hHO-1 was constructed and then introduced into the VSMC, the abundant virus titers as 1.3×106CFU/ml were obtained, indicating the sufficient infection rate of hHO-1 recombinant. Moreover, it had been shown in Southern, Northern and Western blot that the hHO-1 cDNA was reliably integrated into the host chromosomal DNA and could be efficiently transcribed and translated. The increase in HO-1 protein expression was parallel to its enhancing activity in hHO-1 transfected VSMC compared with the control cells. Furthermore, hHO-1 mRNA signals could be obviously detected after 25 passages of VSMC/HO-1 cells. The above results indicated that the construction strategy of the recombinant vector was correctly performed and the retrovirus containing hHO-1 could be stably and efficiently expressed in transfected-VSMC. In fact, several other transgenic cell lines for expression of the specific target genes had been established in this lab by using retroviral 11, 20.
To date, three types of HO isoenzymes named as HO-1, 2, 3 and encoded by different genes have been identified21,22. In vascular system, only HO-1 and HO-2 are expressed. HO-2 is a constitutive protein that plays a regulatory role in physiological process. As previous report, HO-1 is proposed as a protective protein as heat shock protein that is inducible by a number of stressful stimuli, such as hypoxia, heavy metals, oxidant-LDL and endotoxin. It was suggested in the considerable data that the increase in HO-1 expression in different cell types such as endothelial cells23, cardiomyocytes24, fibroblasts 25 etc may yield protective effect on the insulated cells against oxidation injury. Clark26 reported that hemin-mediated increase in HO-1 protein expression resulted in high resistance to VSMC injury caused by an oxidant-generating system, but expression of HO-1 induced by hemin pre-treatment appeared non-tissue specific. In this study, more direct findings were obtained that hHO-1 gene-expressed VSMC could raise obvious resistance against free radical injury of H2O2. Moreover, the protection of HO-1 gene was reasonable declined if the transfected cells were pretreated with HO-1 specific inhibitor ZnPP-IX for 24 h. It implies that the HO-1, apart from classical free radical scavengers, could be an alternative molecule to protect the vascular cells during oxidant-injury. Although the precise mechanisms by which HO-1 confers to such cellular protection have not been fully understood, the following hypotheses relevant to this protection have been taken into account: a) depletion of the oxidant heme, as well as production of biliverdin and bilirubin which are important physiological OFR scavengers27, b) elevation of intracellular Fe2+ level to facilitate ferritin up-regulation which decreases OFR induction21, c) relaxation of vascular tension and inhibition of platelet aggregation through endogenous CO generation28.
It is reported that active oxygen species is not only harmful to vascular cells, but also might be act as stimuli to VSMC growth29. Since the VSMC were supposed to migrate from medial layer into the new-grown intima and are rapidly proliferated as consequence of endothelial damage, therefore it has been believed that accumulation of “immigrant VSMC” play an important role for the initiation of atherosclerosis. Our results showed that overexpression of HO-1 could protect cells against oxidant-injury on one hand, importantly, increase of HO-1 activity might suppress VSMC proliferation on the other. More recently, Liu and colleagues30 reported that adenovirus-mediated HO-1 expression could stimulate apoptosis in VSMC. As more confirmed evidence, we here reported that overexpression of HO-1 in the transfected VSMC could slow down the cell growth. It was revealed that CO derived from VSMC could increase vascular cGMP and arrest the proliferation of hypoxic VSMC31, 32, however, there are no doubt some precise molecular mechanisms for these effects remain uncovered. We here found for the first time that there might exist some intrinsic relationships between the anti-proliferative effect of HO-1 and the decrease of MAPK phosphorylation. Suhasini33 reported that G-kinase inhibited the Ras/MAPK pathway at the level of c-Raf kinase. For this reason characterization of MAPK activity and its mediated- signaling in HO-1 transfected cell will probably explain the mechanisms of cell-growth arrest. The paradoxical phenomenon of cGMP enhancement with MAPK dephosphorylation in the transfected cells reflexes “cross talk” between these two signaling cascades, thereafter, the increase of cGMP might be apparently a counter-regulatory mechanism for attenuating the MAPK activation pathway.
It has been emphasized that ORF is involved in fundamental pathogenesis in many diseases such as atherosclerosis, hypertension, ischemia-reperfusion injury. In the progress of atherosclerosis, under certain circumstances when some of the critical anti-oxidant enzymes including glutathione and superoxide dismutase (SOD) were reduced and the production of NO in endothelial cells was diminished, the activation of HO/CO pathway will build up an alternative important defense against oxidative insult. Recently, Juan et al34 reported that adenovirus-mediated HO-1 gene transfer could inhibit the development of atherosclerosis in apoE-deficient mice. We here found that the over-expression of hHO-1 in the transfected VSMC could directly and significantly inhibit VSMC proliferation. Therefore, the activation of HO/CO signal pathway might be speculated to prevent the formation and development of atherosclerosis, particularly by restoring the balance of anti-oxidants and pro-oxidants in the vascular wall, inhibiting cell proliferation and maintaining blood flow.
References
Galbraith R . Heme oxygenase: who needs it?. PSEBM 1999; 222:299–305.
Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103:129–35.
Poss KD, Tonegawa S . Reduced stress defense in heme oxygenase-1 deficient cells. Proc Natl Acad Sci USA 1997; 94:10925–30.
Witztum JL, D. Steinberg . Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88:1785–92.
Schwartz SM, D deBlois, ER Orien . The intima: soil for atherosclerosis and restenosis. Circ Res 1995; 77:445–65.
Yoshida T, Maulik N, Ho YS, Alam J, Das DK . Hmox-1 constitutes an adaptive response to effect antioxidant cardioprotection. Circulation 2001; 103:1695–701.
Lapenna D, de Gioia S, Ciofani G et al. Glutathione-related antioxidant defences in human atherosclerotic plaques. Circulation 1998; 97:1930–34.
Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY . Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998; 152:711–20.
Scarpa M, Cournoyer D, Muzny DM, Moore KA, Belmont JW, Caskey CT . Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines. Virology 1991; 180(2):849–52.
Cepko C . Introduction of DNA into mammalian cells. In: Ausubel FM, Brent R, Kingston RE, eds. Short Protocols in Molecular Biology, 3rd ed. New York: John Wiley & Sons, 1995, 1–49.
Bai JX, Zhu XG, Zheng XC, Wu YJ . Overexpression of CuZnSOD gene suppresses the growth of hepatocellular cancer cell line HepG2. Chinese Medical Journal 1998; 111(9):789–92.
Vesely MJJ, Exon DJ, Clark JE, Foresti R, Green CJ, Motterlini R . Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. Am J Physiol 1998; 275:C1087–94.
Li YM, Liu JC, Zhang M et al. Alterations of heme oxygenase in cardiovascular system of rat during sepsis. J Beijing Med Univ 1999; 31:497–500. (in Chinese with English abstract)
Wroblewski F . Lactate dehydrogenase activity in blood. Proc Sci Exp Biol Med 1995; 90:210–8.
Goodwin CJ, Holt SJ, Downes S, Marshall NJ . Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS. J Immunol Methods 1995; 179(1):95–103.
Ohtsubo M, Roberts JM . Cyclin dependent regulation of G1 in mammalian fibroblasts. Science 1993; 259:1908–11.
Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI . Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 2001; 104:2710–5.
Senior K . Gene therapy: a rocky start to the new millennium. Mol Med Today 2000; 6(3):93.
Romano G, Pacilio C, Giordano A . Gene transfer technology in Therapy: current applications and future goals. Stem Cells 1999; 17:191–202.
Gao D, An W, Dai J . Retrovirus-mediated herpes simples virus thymidine kinase gene therapy approach for hepatocellular carcinoma. Cell Research 1999; 9:225–35.
Maines MD . The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37:517–54.
McCoubrey WK, Huang TJ, Maines MD . Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247:725–32.
Yang LM, Shuo Q, Abraham NG . Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol 1999; 277:L127–33.
Borger DR, Essig DA . Induction of HSP32 gene in hypoxic cardiomyocytes is attenuated by treatment in N-acetyl-1-cysteine. Am J Physiol 1998; 274:H965–73.
Dennery PA, Sridhar KJ, Lee CS, Wong HE, Shokoohi V, Rodgers PA, Spitz DR . Heme oxygenase-mediated resistance to oxygen toxicity in hamster fibroblasts. J Biol Chem 1997; 272:14937–42.
Clark JE, Foresti R, Green CJ, Motterlini R . Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000; 348:615–9.
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN . Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043–46.
Foresti R, Motterlini R . The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Rad Res 1999; 31:459–75.
Rao GN, BC Berk . Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70:593–99.
Liu XM, Chapman GB, Wang H, Durante W . Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells. Circulation 2002; 105:79–84.
Morita T, Perrella MA, Lee ME, Kourembanas S . Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92:1475–9.
Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S . Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 1997; 272:32804–9.
Suhasini M, Li H, Lohmann SM, Boss GR, Pilz RB . Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway. Mol Cell Biol 1998; 18:6983–94.
Juan SH, Lee TS, Tseng KW et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 104:1519–25.
Acknowledgements
This work was kindly supported by National Natural Science Foundation of China (No. 39670308).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
ZHANG, M., ZHANG, B., CHEN, L. et al. Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res 12, 123–132 (2002). https://doi.org/10.1038/sj.cr.7290118
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.cr.7290118
Keywords
This article is cited by
-
PDGF-D promotes dermal fibroblast invasion in 3-dimensional extracellular matrix via Snail-mediated MT1-MMP upregulation
Tumor Biology (2016)
-
Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model
Cell Stress and Chaperones (2015)
-
An aqueous extract of Zingiber officinale Roscoe protects mouse primary hepatic cells against hydrogen peroxide-induced oxidative stress
Biotechnology and Bioprocess Engineering (2012)
-
Celastrol Attenuates Hypertension-Induced Inflammation and Oxidative Stress in Vascular Smooth Muscle Cells via Induction of Heme Oxygenase-1
American Journal of Hypertension (2010)
-
Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity
Cell Biology and Toxicology (2008)